HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas R Martin Selected Research

Death Domain Receptors

7/2011Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury.
1/2005Apoptosis and epithelial injury in the lungs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas R Martin Research Topics

Disease

19Lung Injury
01/2022 - 04/2003
19Inflammation (Inflammations)
09/2013 - 02/2002
12Acute Lung Injury
09/2013 - 02/2003
12Pneumonia (Pneumonitis)
08/2012 - 02/2003
9Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 04/2003
7Infections
12/2012 - 10/2008
4Cystic Fibrosis (Mucoviscidosis)
01/2022 - 05/2010
4Sepsis (Septicemia)
02/2016 - 01/2006
2Lung Diseases (Lung Disease)
01/2022 - 08/2020
2Critical Illness (Critically Ill)
08/2020 - 08/2006
2Chronic Obstructive Pulmonary Disease (COPD)
03/2016 - 01/2016
2Virus Diseases (Viral Diseases)
03/2012 - 10/2011
2Hyperthermia
07/2011 - 04/2010
2Multiple Organ Failure (MODS)
01/2006 - 01/2003
2Endotoxemia
01/2006 - 02/2005
1Asthma (Bronchial Asthma)
01/2022
1COVID-19
01/2022
1Neoplasms (Cancer)
01/2022
1Thrombotic Thrombocytopenic Purpura
02/2016
1Thrombosis (Thrombus)
02/2016
1Chronic Bronchitis
01/2016
1Edema (Dropsy)
09/2013
1Coinfection
06/2012
1Peritonitis
06/2012
1Cytokine Release Syndrome
03/2012
1Communicable Diseases (Infectious Diseases)
03/2012
1Respiratory Syncytial Virus Infections
10/2011
1Bacteremia
02/2009
1Pulmonary Edema
01/2009
1Pneumovirus Infections
01/2009
1Bone Fractures (Bone Fracture)
09/2008
1Embolism (Embolus)
09/2008
1Ischemia
09/2008
1Wounds and Injuries (Trauma)
05/2008

Drug/Important Bio-Agent (IBA)

11CytokinesIBA
01/2016 - 10/2003
8LipopolysaccharidesIBA
08/2012 - 03/2004
6Fas Ligand Protein (Fas Ligand)IBA
10/2011 - 04/2003
5ChemokinesIBA
07/2011 - 05/2003
4Biomarkers (Surrogate Marker)IBA
03/2016 - 01/2005
4Proteins (Proteins, Gene)FDA Link
09/2013 - 01/2004
3Biological ProductsIBA
01/2022 - 03/2006
3AcidsIBA
07/2011 - 04/2003
3Interleukin-8 (Interleukin 8)IBA
02/2010 - 02/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2010 - 01/2004
2von Willebrand FactorIBA
02/2016 - 02/2010
2Surface-Active Agents (Surfactants)IBA
07/2013 - 01/2004
2Toll-Like Receptors (Toll-Like Receptor)IBA
08/2012 - 10/2008
2Anti-Bacterial Agents (Antibiotics)IBA
06/2012 - 05/2010
2AntibodiesIBA
06/2012 - 01/2005
2Death Domain ReceptorsIBA
07/2011 - 01/2005
2AntigensIBA
02/2010 - 02/2003
1Fibrinogen (Factor I)FDA Link
03/2016
1Pharmaceutical PreparationsIBA
03/2016
1Apolipoprotein A-I (Apolipoprotein A1)IBA
02/2016
1HDL LipoproteinsIBA
02/2016
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2016
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2016
1fas Receptor (CD95 Antigen)IBA
09/2013
1PhenazinesIBA
12/2012
1phenazineFDA Link
12/2012
1GlycosaminoglycansIBA
08/2012
1Heparitin Sulfate (Heparan Sulfate)IBA
08/2012
1Proteoglycans (Proteoglycan)IBA
08/2012
1Syndecan-4IBA
08/2012
1Immune Sera (Antisera)IBA
06/2012
1Polysaccharides (Glycans)IBA
06/2012
1Interleukin-17 (Interleukin 17)IBA
10/2011
1TachykininsIBA
10/2011
1Type I Tumor Necrosis Factor ReceptorsIBA
07/2011
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
07/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2011
1Eicosapentaenoic AcidIBA
07/2011
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
07/2011
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
07/2011
1Fish OilsIBA
07/2011
1Panton-Valentine leukocidinIBA
03/2010
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
02/2010
1Protein CIBA
02/2010
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2010
1Plasminogen Activator Inhibitor 1IBA
02/2010
1InterleukinsIBA
02/2010
1Clodronic Acid (Clodronate)IBA
02/2009
1AlbuminsIBA
02/2009
1CaspasesIBA
01/2009
1Toll-Like Receptor 1IBA
10/2008
1LipidsIBA
09/2008
1EndotoxinsIBA
06/2008
1Toll-Like Receptor 4IBA
06/2008
1Monoclonal AntibodiesIBA
06/2008
1Peroxidase (Myeloperoxidase)IBA
11/2007

Therapy/Procedure

13Artificial Respiration (Mechanical Ventilation)
10/2011 - 01/2003
3Mechanical Ventilators (Ventilator)
07/2013 - 09/2004
3Positive-Pressure Respiration (Positive End-Expiratory Pressure)
02/2010 - 01/2004
2Therapeutics
01/2022 - 01/2022
2Blood Transfusion (Blood Transfusions)
05/2008 - 01/2003
1Precision Medicine
01/2022
1Critical Care (Surgical Intensive Care)
08/2020
1Immunotherapy
06/2012
1Immunomodulation
03/2012
1Catheters
01/2009